Related references
Note: Only part of the references are listed.Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series
Aini Haddouche et al.
JOURNAL OF DIABETES (2020)
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA
Jaclyn F. Hechtman et al.
HUMAN PATHOLOGY (2019)
Natural history of liver adenomatosis: A long-term observational study
Louise Barbier et al.
JOURNAL OF HEPATOLOGY (2019)
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation
Jean-Charles Nault et al.
GASTROENTEROLOGY (2017)
EASL Clinical Practice Guidelines on the management of benign liver tumours
Massimo Colombo et al.
JOURNAL OF HEPATOLOGY (2016)
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2013)
Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation
J. S. B. Willson et al.
JOURNAL OF HEPATOLOGY (2013)
Changing trends in malignant transformation of hepatocellular adenoma
Olivier Farges et al.
GUT (2011)
Genetic modifiers of the age at diagnosis of diabetes (MODY3) in carriers of hepatocyte nuclear factor-1α mutations map to chromosomes 5p15, 9q22, and 14q24
SH Kim et al.
DIABETES (2003)
Bi-allelic inactivation of TCF1 in hepatic adenomas
O Bluteau et al.
NATURE GENETICS (2002)
Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus
JP Weng et al.
DIABETES CARE (2002)
Share Paper
